Treatment Algorithms: disease of the skin - Prescribing trends mirror guidelines SYS-CON Media (press release) However, biologics Enbrel (etanercept; Amgen/Pfizer), Humira (adalimumab; Abbott/Eisai), and Stelara (ustekinumab; Janssen Biotech) continue to reshape the management of moderate to severe disease of the skin patients. This trend is expected to continue concluded the ... and more » Link To Article
No comments:
Post a Comment